logo
  

Intevac Inc. Q1 Loss Narrows

Intevac Inc. (IVAC) reported Loss for first quarter that decreased from the same period last year

The company's bottom line came in at -$1.6 million, or -$0.06 per share. This compares with -$3.9 million, or -$0.15 per share, in last year's first quarter.

Excluding items, Intevac Inc. reported adjusted earnings of -$2.7 million or -$0.10 per share for the period.

The company's revenue for the quarter fell 16.5% to $9.6 million from $11.5 million last year.

Intevac Inc. earnings at a glance (GAAP) :

-Earnings (Q1): -$1.6 Mln. vs. -$3.9 Mln. last year.
-EPS (Q1): -$0.06 vs. -$0.15 last year.
-Revenue (Q1): $9.6 Mln vs. $11.5 Mln last year.

For comments and feedback contact: editorial@rttnews.com

This week, we bring a mix of medical breakthroughs and setbacks. Lyko's MDMA therapy could become the first FDA-approved psychedelic treatment if all goes well as planned. A tragic loss occurred in Pfizer's Duchenne trial and a new study has raised concerns about ultra-processed foods. Find out why Long Beach declared a public health emergency and how Novavax's actions signal optimism.

View More Videos
RELATED NEWS
Follow RTT